ASTELLAS-015K-CL-CNA3

Study Sponsor: Astellas

Study Title

A Randomized, Double-Blind, Placebo-Controlled Confirmatory Study of the Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response or Intolerance to MTX

Medicine or Vaccine (generic name)

peficitinib hydrobromide

Sponsor Identification Number

015K-CL-CNA3

Trial Registry Identification Number(#'s)

NCT03660059

Medical Condition

Rheumatoid Arthritis

Phase

Phase 3

Link to Astellas Study Register

https://www.clinicaltrials.astellas.com/study/015K-CL-CNA3/

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT03660059

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2024